Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Condition: Thyroid Cancer Intervention: Drug: Pembrolizumab (Keytruda) Sponsors: Stanford University; Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Research | Thyroid | Thyroid Cancer | Undifferentiated Carcinoma